NEW YORK (GenomeWeb News) - Molecular Devices’ shares surged 47 percent in afternoon trading to $35.05 from Friday’s close of $23.38, in the wake of this morning’s announcement that the company will be bought by MDS.
MDS said earlier today that it will pay $615 million in cash for Molecular Devices and combine the firm with its MDS Sciex business.
MDS’ stock was up 1.17 percent to $17.30.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic analysis of pollutant-tolerant fish, and more.
Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.
New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.
NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.